United States · Series B startup
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$46Mraised across 2 rounds since 2013, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
RA Capital Management
Hatteras Venture Partners
Mountain Group Partners
Lumira Ventures
Eshelman VenturesFrom a historical funding recordSEC filing: $17M sold, first sale Feb 2015
Reported by finsmes.comSEC filing: $6.3M sold, first sale Oct 2013
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
G1 Therapeutics, Inc.'s investors include Hatteras Venture Partners, Mountain Group Partners, MedImmune Ventures, RA Capital Management and Lumira Ventures, and 1 more on record.
G1 Therapeutics, Inc. has raised $46M across 2 rounds since 2013.
G1 Therapeutics, Inc.'s most recent round was a Series B of $33M in Feb 2015.
Its most recent round, $33M in Feb 2015, is also its largest on record.
G1 Therapeutics, Inc.'s first round on record, in Oct 2013, was backed by Hatteras Venture Partners, Mountain Group Partners and MedImmune Ventures.
G1 Therapeutics, Inc.'s latest named round is a Series B, in Feb 2015.
G1 Therapeutics, Inc. is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·